Kodiak Sciences to Host Investor R&D Day on July 16, 2025

Core Insights - Kodiak Sciences Inc. is hosting an investor R&D Day webcast on July 16, 2025, from 4:00 pm ET to 5:30 pm ET, focusing on its late-phase clinical assets [1][2]. Company Overview - Kodiak Sciences is a precommercial biotechnology company focused on retinal diseases, aiming to develop transformative therapeutics to prevent and treat blindness globally [4]. - The company utilizes its ABC Platform®, which integrates protein-based and chemistry-based therapies, as the foundation of its discovery engine [4]. - Kodiak's pipeline includes three late-phase clinical assets, all targeting Phase 3 topline data expected in 2026 [4]. Event Details - The webcast will feature presentations from Kodiak's senior leadership and industry experts, providing a comprehensive overview of its three late-phase clinical assets: tarcocimab, KSI-501, and KSI-101 [2]. - Registration for the event is available online, and a recording will be accessible 24 hours post-event [3].